Wenting Dai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wenting Dai has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Cheng Zhao
Xinhua Hospital 1 Department of General Surgery Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
16 shared publications - Danyang Shen
The First Affiliated Hospital of Soochow University 6 Department of General Surgery Suzhou, China
16 shared publications - Jiayun Zhu
Department of General Surgery Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Biliary Tract Disease Research Shanghai China
16 shared publications - Jingwei Zhao
Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
16 shared publications - Lin Jiang
Xinhua Hospital 1 Department of General Surgery Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
16 shared publications - Liuqing Shi
Xinhua Hospital 1 Department of General Surgery Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
16 shared publications
Latest Publications
- Open Access
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Validation of RIPK1S166A mutant
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Validation of RIPK1S166A mutant
- Open Access
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Verification of Tumor-derived EVs trigger neuron necroptosis
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Verification of Tumor-derived EVs trigger neuron necroptosis
- Open Access
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
LDH release assay of eight cell death models
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
LDH release assay of eight cell death models
- Open Access
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S10 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Homology alignment of human versus mouse RIPK1 protein sequences
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S10 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Homology alignment of human versus mouse RIPK1 protein sequences
- Open Access
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Biosafety evaluation of the small molecule inhibitor FPS-ZM1
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Biosafety evaluation of the small molecule inhibitor FPS-ZM1
- Open Access
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Data from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Peripheral nerve invasion (PNI) is an early and decisive step in gallbladder cancer progression that strongly predicts poor postsurgical outcome. The tumor–neuron interactions that drive PNI could represent potential targets and biomarkers to improve treatment of gallbladder cancer. In this study, we demonstrated that gallbladder cancer provoked necroptosis of neurons to enable PNI. Gallbladder cancer cells transferred extracellular vesicles (EV) containing O-GlcNAcase (OGA) to neurons, which activated RIPK1-dependent necroptosis. Mechanistically, EV-derived OGA suppressed RIPK1 glycosylation while enhancing its phosphorylation, thereby activating the RIPK1/RIPK3/MLKL axis to trigger neuronal necroptosis. Subsequent neuronal release of HMGB1 engaged RAGE on gallbladder cancer cells, establishing a loop that accelerated PNI. Moreover, the RAGE antagonist FPS-ZM1 synergized with gemcitabine to suppress tumor progression. Collectively, these findings uncover an EV-mediated cross-talk between gallbladder cancer cells and neurons in which RIPK1-dependent necroptosis and its effector HMGB1 drive PNI, positioning the HMGB1–RAGE axis as a tractable therapeutic target.Significance:Tumor-derived extracellular vesicles trigger neuronal necroptosis that fuels peripheral nerve invasion, creating a tumor-neuron signaling loop that could be leveraged for liquid biopsy and personalized therapy strategies in neurotropic cancers.
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Peripheral nerve invasion (PNI) is an early and decisive step in gallbladder cancer progression that strongly predicts poor postsurgical outcome. The tumor–neuron interactions that drive PNI could represent potential targets and biomarkers to improve treatment of gallbladder cancer. In this study, we demonstrated that gallbladder cancer provoked necroptosis of neurons to enable PNI. Gallbladder cancer cells transferred extracellular vesicles (EV) containing O-GlcNAcase (OGA) to neurons, which activated RIPK1-dependent necroptosis. Mechanistically, EV-derived OGA suppressed RIPK1 glycosylation while enhancing its phosphorylation, thereby activating the RIPK1/RIPK3/MLKL axis to trigger neuronal necroptosis. Subsequent neuronal release of HMGB1 engaged RAGE on gallbladder cancer cells, establishing a loop that accelerated PNI. Moreover, the RAGE antagonist FPS-ZM1 synergized with gemcitabine to suppress tumor progression. Collectively, these findings uncover an EV-mediated cross-talk between gallbladder cancer cells and neurons in which RIPK1-dependent necroptosis and its effector HMGB1 drive PNI, positioning the HMGB1–RAGE axis as a tractable therapeutic target.Significance:Tumor-derived extracellular vesicles trigger neuronal necroptosis that fuels peripheral nerve invasion, creating a tumor-neuron signaling loop that could be leveraged for liquid biopsy and personalized therapy strategies in neurotropic cancers.
- Open Access
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Generalization verification in eight classic cell death models
- 16 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Extracellular Vesicle–Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion
Generalization verification in eight classic cell death models